Published in J Exp Med on July 01, 1994
Iron acquisition and metabolism by mycobacteria. J Bacteriol (1999) 2.71
Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect Immun (1999) 1.65
Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun (1998) 1.43
Lipid composition and transcriptional response of Mycobacterium tuberculosis grown under iron-limitation in continuous culture: identification of a novel wax ester. Microbiology (2007) 1.13
Identification of an Immunomodulating Agent from Mycobacterium leprae. Infect Immun (2005) 1.03
Proteome analysis of the plasma membrane of Mycobacterium tuberculosis. Comp Funct Genomics (2002) 0.98
Molecular definition and identification of new proteins of Mycobacterium leprae. Infect Immun (1996) 0.95
Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein. Infect Immun (1998) 0.94
Bacterioferritin from Mycobacterium smegmatis contains zinc in its di-nuclear site. Protein Sci (2008) 0.93
A histone-like protein of mycobacteria possesses ferritin superfamily protein-like activity and protects against DNA damage by Fenton reaction. PLoS One (2011) 0.90
Survival of a bacterioferritin deletion mutant of Brucella melitensis 16M in human monocyte-derived macrophages. Infect Immun (1997) 0.89
Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infect Immun (2006) 0.88
Serological distinction of integral plasma membrane proteins as a class of mycobacterial antigens and their relevance for human T cell activation. Clin Exp Immunol (1995) 0.83
Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae. Infect Immun (2006) 0.83
B cell diversification and differentiation in the periphery. J Exp Med (1994) 0.81
IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy. PLoS Negl Trop Dis (2014) 0.80
Serological diagnosis of leprosy in patients in vietnam by enzyme-linked immunosorbent assay with Mycobacterium leprae-derived major membrane protein II. Clin Vaccine Immunol (2008) 0.79
An antifungal protein from the marine bacterium streptomyces sp. Strain AP77 is specific for Pythium porphyrae, a causative agent of red rot disease in Porphyra spp. Appl Environ Microbiol (2002) 0.79
Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake. J Bacteriol (2016) 0.78
The challenge of producing skin test antigens with minimal resources suitable for human application against a neglected tropical disease; leprosy. PLoS Negl Trop Dis (2014) 0.77
Analysis of antigens of Mycobacterium leprae by interaction to sera IgG, IgM, and IgA response to improve diagnosis of leprosy. Biomed Res Int (2014) 0.77
Role of Subunit Exchange and Electrostatic Interactions on the Chaperone Activity of Mycobacterium leprae HSP18. PLoS One (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Nucleotide sequence of the E coli gene coding for dihydrofolate reductase. Nucleic Acids Res (1980) 8.75
Genetic systems for mycobacteria. Methods Enzymol (1991) 7.50
Role of iron in regulation of virulence genes. Clin Microbiol Rev (1993) 5.00
Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem (1987) 4.98
Multiplex DNA sequencing. Science (1988) 3.70
Mycobacterial protein antigens: a compilation. Mol Microbiol (1992) 3.35
Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem (1982) 3.11
Growth and metabolic characteristics of Mycobacterium paratuberculosis. Appl Microbiol (1974) 2.66
Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect Immun (1992) 2.61
Nucleotide sequence of the first cosmid from the Mycobacterium leprae genome project: structure and function of the Rif-Str regions. Mol Microbiol (1993) 2.45
The composition and the structure of bacterioferritin of Escherichia coli. Biochem J (1981) 2.15
The major native proteins of the leprosy bacillus. J Biol Chem (1990) 1.96
Perspectives in iron metabolism. N Engl J Med (1982) 1.77
Use of an ordered cosmid library to deduce the genomic organization of Mycobacterium leprae. Mol Microbiol (1993) 1.73
Mössbauer spectroscopy of Escherichia coli and its iron-storage protein. Biochim Biophys Acta (1980) 1.73
Cloning, sequencing, and mapping of the bacterioferritin gene (bfr) of Escherichia coli K-12. J Bacteriol (1989) 1.71
Microsequence analysis of peptides and proteins. V. Design and performance of a novel gas-liquid-solid phase instrument. Anal Biochem (1985) 1.48
Estimated number of leprosy cases in the world. Bull World Health Organ (1992) 1.38
Isolation and properties of the complex nonheme-iron-containing cytochrome b557 (bacterioferritin) from Pseudomonas aeruginosa. J Inorg Biochem (1987) 1.34
Microsequence analysis of peptides and proteins. VI. A continuous flow reactor for sample concentration and sequence analysis. Anal Biochem (1987) 1.32
Enzymatic and chemical digestion of proteins for mass spectrometry. Methods Enzymol (1990) 1.22
Bis-methionine axial ligation of haem in bacterioferritin from Pseudomonas aeruginosa. Nature (1990) 1.20
Mycobacterium paratuberculosis antigen D: characterization and evidence that it is a bacterioferritin. J Clin Microbiol (1991) 1.15
A simple and rapid purification of commercial trypsin and chymotrypsin by reverse-phase high-performance liquid chromatography. Anal Biochem (1982) 1.12
Unification of the ferritin family of proteins. Proc Natl Acad Sci U S A (1992) 1.09
Nucleotide sequence of the 16S rRNA from Mycobacterium leprae. Nucleic Acids Res (1990) 1.07
Molecular size and symmetry of the bacterioferritin of Escherichia coli. X-ray crystallographic characterization of four crystal forms. J Mol Biol (1989) 1.06
Chromatographic purification and characterization of antigens A and D from Mycobacterium paratuberculosis and their use in enzyme-linked immunosorbent assays for diagnosis of paratuberculosis in sheep. J Clin Microbiol (1991) 1.05
Iron metabolism of Escherichia coli studied by Mössbauer spectroscopy and biochemical methods. Eur J Biochem (1989) 1.01
Purification, characterization and function of bacterioferritin from the cyanobacterium Synechocystis P.C.C. 6803. Biochem J (1992) 0.99
The identity of Escherichia coli bacterioferritin and cytochrome b1. Biochem J (1988) 0.94
Iron transport in Mycobacterium smegmatis: occurrence of iron-regulated envelope proteins as potential receptors for iron uptake. J Gen Microbiol (1987) 0.93
Analysis of peptide mixtures by capillary high performance liquid chromatography: a practical guide to small-scale separations. Protein Sci (1992) 0.89
Molecular-genetic evidence for the relationship of Mycobacterium leprae to slow-growing pathogenic mycobacteria. Int J Lepr Other Mycobact Dis (1988) 0.88
The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis. Histopathology (1991) 0.78
Recent research into the physiology of Mycobacterium leprae. Adv Microb Physiol (1990) 0.77
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 19.34
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
Controlling electromagnetic fields. Science (2006) 14.27
A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (2002) 13.50
A genetic linkage map of the human genome. Cell (1987) 13.37
Metamaterial electromagnetic cloak at microwave frequencies. Science (2006) 11.18
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet (1994) 9.20
Nucleotide sequence of the E coli gene coding for dihydrofolate reductase. Nucleic Acids Res (1980) 8.75
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Experimental verification of a negative index of refraction. Science (2001) 8.05
Genome sequence and comparative analysis of the solvent-producing bacterium Clostridium acetobutylicum. J Bacteriol (2001) 6.46
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother (1994) 6.39
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science (1985) 6.31
Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol (1999) 6.26
Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest (1976) 5.96
A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol (1997) 5.28
Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol (1987) 5.13
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol (1997) 5.09
CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03
Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science (1997) 4.96
Perfect metamaterial absorber. Phys Rev Lett (2008) 4.69
Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem (1986) 4.52
Are general practitioners doing enough to promote healthy lifestyle? Findings of the Medical Research Council's general practice research framework study on lifestyle and health. Br Med J (Clin Res Ed) (1987) 4.48
Genome organization of the anaerobic pathogen Clostridium perfringens. Proc Natl Acad Sci U S A (1989) 4.21
Domains of the positive transcription factor specific for the Xenopus 5S RNA gene. Cell (1984) 4.19
Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J (1986) 4.15
Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol (1995) 3.98
Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol (1990) 3.85
Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber Lung Dis (1999) 3.82
Seasonal variation in arterial blood pressure. Br Med J (Clin Res Ed) (1982) 3.82
High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA (1998) 3.81
Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol Rev (1991) 3.81
Single-target molecule detection with nonbleaching multicolor optical immunolabels. Proc Natl Acad Sci U S A (2000) 3.78
An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A (1996) 3.78
Broadband ground-plane cloak. Science (2009) 3.69
Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics. Infect Immun (1998) 3.65
Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob Agents Chemother (1993) 3.46
Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG. Infect Immun (1984) 3.46
Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med (1994) 3.25
Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem (1982) 3.11
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Structural studies on the type-specific antigens and lipids of the mycobacterium avium. Mycobacterium intracellulare. Mycobacterium scrofulaceum serocomplex. Mycobacterium intracellulare serotype 9. J Biol Chem (1979) 3.00
Accurate detection of coronary heart disease by new exercise test. Br Heart J (1982) 2.97
Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1989) 2.93
Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect Immun (1999) 2.84
The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci U S A (1996) 2.83
Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun (1991) 2.77
Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J Bacteriol (1993) 2.72
The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol Microbiol (1995) 2.71
A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol (1981) 2.70
Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature (1984) 2.63
Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer. Mol Microbiol (1989) 2.62
Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect Immun (1992) 2.61
Memory metamaterials. Science (2009) 2.61
Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis (1988) 2.56
Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol Microbiol (1995) 2.45
Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem (2000) 2.43
Streptomycin resistance in mycobacteria. Antimicrob Agents Chemother (1994) 2.40
Identification of atypical mycobacteria by thin-layer chromatography of their surface antigens. J Clin Microbiol (1978) 2.40
The national AHEC program: review of its progress and considerations for the 1980s. Public Health Rep (1981) 2.34
Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun (1992) 2.33
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med (1999) 2.33
Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect Immun (1983) 2.30
Thin-layer chromatography of lipid antigens as a means of identifying nontuberculous mycobacteria. J Clin Microbiol (1982) 2.29
Resonant and antiresonant frequency dependence of the effective parameters of metamaterials. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 2.29
Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J Biol Chem (1992) 2.28
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol (1987) 2.27
Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls. J Biol Chem (1990) 2.25
Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thromb Haemost (1992) 2.24
New insertion sequences and a novel repeated sequence in the genome of Mycobacterium tuberculosis H37Rv. Microbiology (1999) 2.22
Mitral valve replacement with aortic heterografts in humans. Thorax (1967) 2.22
Peptidoglycolipid nature of the superficial cell wall sheath of smooth-colony-forming mycobacteria. J Bacteriol (1980) 2.21
Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect Immun (1988) 2.21
Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol (1986) 2.20
Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J Biol Chem (1990) 2.20
A rapid method for the detection of potentially viable Mycobacterium leprae in human biopsies: a novel application of PCR. FEMS Microbiol Lett (1989) 2.20
Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology (1995) 2.19
Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J Biol Chem (1994) 2.18
Cloning, mapping, and molecular characterization of the rRNA operons of Clostridium perfringens. J Bacteriol (1991) 2.18
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother (1995) 2.17
Patient-Centered Patient-Valued Care. J Health Care Poor Underserved (1991) 2.14
Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14
Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene. J Bacteriol (1986) 2.12
Location and nucleotide sequence of frdB, the gene coding for the iron-sulphur protein subunit of the fumarate reductase of Escherichia coli. Eur J Biochem (1982) 2.10
Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J Bacteriol (1990) 2.10
Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09
Genomic diversity and organization of virulence genes in the pathogenic anaerobe Clostridium perfringens. Mol Microbiol (1992) 2.09
Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology (1996) 2.08
Expression of individual Ia specificities on T and B cells. I. Studies with mitogen-induced blast cells. J Exp Med (1976) 2.08
Methanogenesis: genes, genomes, and who's on first? J Bacteriol (1997) 2.06
Terahertz magnetic response from artificial materials. Science (2004) 2.05
Phosphatidylinositol is an essential phospholipid of mycobacteria. J Biol Chem (2000) 2.03
Effects of isoniazid on the composition of mycobacteria, with particular reference to soluble carbohydrates and related substances. Biochem J (1967) 2.02